Tivic Health Systems Inc (TIVC)

Currency in USD
3.250
+0.200(+6.55%)
Real-time Data·
TIVC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
TIVC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.0703.660
52 wk Range
2.43015.640
Key Statistics
Prev. Close
3.05
Open
3.57
Day's Range
3.07-3.66
52 wk Range
2.43-15.64
Volume
14.45M
Average Volume (3m)
748.92K
1-Year Change
-46.06%
Book Value / Share
4.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TIVC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Tivic Health Systems Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Tivic Health Systems Inc Company Profile

Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relief brand name. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.

Tivic Health Systems Inc Earnings Call Summary for Q2/2025

  • Q2 2025 revenue fell to $86,000 from $140,000 in Q2 2024; gross margins improved to 63% from 21% year-over-year
  • Strategic pivot to biopharmaceuticals, focusing on immune system therapies; plans to exit consumer health tech by year-end
  • Raised $900,000 post-quarter to support initiatives; cash and equivalents at $1.2 million as of June 30, 2025
  • Developing Entolimod for acute radiation syndrome; FDA Fast Track and Orphan Drug designations received
  • Analysts anticipate 9.3% sales growth for FY 2025; upcoming milestones include IND transfers and GMP manufacturing validation
Last Updated: 14/08/2025, 22:10
Read Full Transcript

Compare TIVC to Peers and Sector

Metrics to compare
TIVC
Peers
Sector
Relationship
P/E Ratio
−0.6x−4.0x−0.6x
PEG Ratio
−0.01−0.140.00
Price/Book
1.0x3.1x2.6x
Price / LTM Sales
7.8x2.8x3.3x
Upside (Analyst Target)
-38.0%40.1%
Fair Value Upside
Unlock12.8%5.3%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-2.19 / --
Revenue / Forecast
86.00K / --
EPS Revisions
Last 90 days

TIVC Income Statement

People Also Watch

7.2250
CYCC
-3.54%
2.36
INMB
-1.86%
8.650
BSLK
+6.66%
50.53
BMNR
+1.51%
14.8500
INKT
+1.02%

FAQ

What Stock Exchange Does Tivic Health Systems Trade On?

Tivic Health Systems is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tivic Health Systems?

The stock symbol for Tivic Health Systems is "TIVC."

What Is the Tivic Health Systems Market Cap?

As of today, Tivic Health Systems market cap is 4.10M.

What Is Tivic Health Systems's Earnings Per Share (TTM)?

The Tivic Health Systems EPS (TTM) is -11.00.

From a Technical Analysis Perspective, Is TIVC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Tivic Health Systems Stock Split?

Tivic Health Systems has split 2 times.

How Many Employees Does Tivic Health Systems Have?

Tivic Health Systems has 7 employees.

What is the current trading status of Tivic Health Systems (TIVC)?

As of 20 Aug 2025, Tivic Health Systems (TIVC) is trading at a price of 3.25, with a previous close of 3.05. The stock has fluctuated within a day range of 3.07 to 3.66, while its 52-week range spans from 2.43 to 15.64.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.